Medical Education and the Harm of ‘Goodly Heritage’
By Daniel Martinez HoSang, Marco Antonio Ramos, and Alana Slavin,
Los Angeles Review of Books
| 02. 08. 2026
"Yale School of Medicine" by Ajay Suresh
via Wikimedia Commons, licensed under CC by 2.0
This is the 12th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in collaboration with the Los Angeles Review of Books, and supported by the Center for Genetics and Society, the Othering & Belonging Institute, and Berkeley Public Health.
¤
EACH YEAR IN LATE August when the summer humidity in southern New England begins to dissipate, first-year medical students take their seats in a tranquil courtyard at the Yale School of Medicine. There, they take part in a ceremony observed at dozens of medical schools across the country. After listening to speeches by esteemed faculty and alumni on the ethical and humanistic aspects of medicine, they line up to receive a white coat and stethoscope to symbolize their entrance into the profession. And then they rise together as one body to recite the Hippocratic oath...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...